Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2023-01-20 00:00:00 ET · period of report 2023-01-19 · accession 0001209191-23-004237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-20 | 2023-01-19 | FATE | MENDLEIN JOHN | Dir | M - OptEx | $1.37 | +28.5K | 311.2K | +10% | +$39.0K |
| D | 2023-01-20 | 2023-01-19 | FATE | MENDLEIN JOHN | Dir | M - OptEx | $0.00 | +28.5K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-19 | M | A | 28,461 | $1.37 | 311,231 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-19 | M | A | 28,461 | $0.00 | 0 | D | $1.37 · — to 2023-02-06 | 28,461 Common Stock | (F1) This stock option is fully vested and exercisable. |